Lupus anticoagulant in human immunodeficiency virus -infected patients on highly active antiretroviral therapy

• Hauptverfasser: Awodu Omolade (VerfasserIn), Olayemi Edeghonghon (VerfasserIn), Bazuaye Godwin (VerfasserIn), Onunu Abel (VerfasserIn)
• Format: Buch
• Veröffentlicht: Wolters Kluwer Medknow Publications, 2010-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

<b>Background:</b> Lupus anticoagulant (LA) is a heterogeneous group of antibodies that causes a variety of clinical and laboratory effects; has been described in infections such as human immunodeficiency virus. LA has not been previously described in Nigerians with human immunodeficienc...